The eyeless inbred mouse strain ZRDCT has long served as a spontaneous model for human anophthalmia and the evolutionary reduction of eyes that has occurred in some naturally blind mammals. ZRDCT mice have orbits but lack eyes and optic tracts and have hypothalamic abnormalities. Segregation data suggest that a small number of interacting genes are responsible, including at least one major recessive locus, ey1. Although predicted since the 1940s, these loci were never identified. We mapped ey1 to chromosome 18 using an F2 genome scan and there found a Met103 Leu mutation in Rx/rax, a homeobox gene that is expressed in the anterior headfold, developing retina, pineal, and hypothalamus and is translated via a leaky scanning mechanism. The mutation affects a conserved AUG codon that functions as an alternative translation initiation site and consequently reduces the abundance of Rx protein. In contrast to a targeted Rx null allele, which causes anophthalmia, central nervous system defects, and neonatal death, the hypomorphic M10L allele is fully viable. genesis 31:43-53, 2001.
INTRODUCTION
The phenotype of ZRDCT mice (Fig. 1a) is similar to human clinical anophthalmia (Duke-Elder, 1964; Kohn et al., 1988) and the rudimentary development of eyes in some fossorial (subterranean) mammals (Cooper et al., 1993) . More than 90% of mice in this inbred strain have no eyes or optic tracts, although the eyelids, bony orbits, palpebral conjunctivae, Harderian glands, and periocular soft tissues are intact (Chase and Chase, 1941; Silver and Hughes, 1974) . Higher visual centers in the brain, including the lateral geniculate nuclei and visual cortex, form normal projections and exhibit normal topographic connectivity but are attenuated (Chase, 1945; Godement et al., 1979; Katz et al., 1981; Olavarria and van Sluyters, 1984; Rhoades et al., 1985) . The hypothalamus has variably distorted anatomy (Laemle and Rusa, 1992; Silver, 1977) and there are intrinsic circadian rhythm disturbances (Faradji-Prevautel et al., 1990; Laemle and Ottenweller, 1998) . The remaining 10% of ZRDCT mice have one or two small eyes with colobomatous defects and no optic nerve . The phenotype is first apparent during lens induction at day E10. The optic vesicles emerge normally from the anterior neural tube but are reduced in size and contact poorly with the surface ectoderm (Chase and Chase, 1941; Harch et al., 1978; Silver and Hughes, 1974; Webster et al., 1984) . In some embryos, there is a small displaced lens placode and limited crystallin synthesis (Konyukhov et al., 1978; Zwaan and Silver, 1983) . The eyeless trait is one of the first developmental defects and first examples of multifactorial inheritance described in laboratory mice.
In crosses between ZRDCT and most other laboratory strains, the eyeless phenotype behaves as a polygenic trait. F1 mice are normal, but 10 -13% of F2 intercross and 20 -25% of N2 backcross progeny are affected (Beck, 1963; Chase, 1942) . On the basis of these experiments, Chase (1944) postulated a major recessive eyeless determinant (ey1) and a modifier (ey2) with partial dominance. In this study, we test this model, identify the ey1 mutation, and characterize its molecular properties in detail.
RESULTS
To map ey1, we performed a pooled genome scan (Taylor et al., 1994) using F2 progeny derived from ZRDCT and CAST/Ei, an inbred strain of the relatively divergent subspecies Mus musculus castaneus. Among 2,316 F2 offspring, we observed 2,109 normal (91.1%), 153 intermediate (6.6%), and 54 bilaterally eyeless (2.3%) mice. The proportion of affected F2 progeny is thus between 1/8 and 1/16. These ratios are similar to segregation data reported for crosses between ZRDCT and conventional laboratory mice (Beck, 1963; Chase, 1942; Chase, 1944) . By screening two pools of bilaterally anophthalmic F2 mice with multiple SSLP (simple sequence length polymorphism) markers, we detected linkage between ey1 and chromosome 18. We then singly tested all 54 eyeless F2 mice using additional markers and a fragment length polymorphism in the second intron of Rx/rax, a retinal homeobox gene previously mapped to this region (Furukawa et al., 1997) (Fig. 1b) . No recombination was observed between Rx and ey1, suggesting that they are located within 2.8 cM (95% CI for n ϭ 108 meioses, with a LOD score in favor of linkage Ͼ30).
The Rx gene is an attractive candidate for ey1 for several reasons. First, it encodes a 342 amino acid transcription factor with four evolutionarily conserved motifs: a paired-class homeodomain, a C-terminal OAR (paired tail) domain (Furukawa et al., 1997; Mathers et al., 1997) , an octapeptide motif near the N-terminus, and a segment of high sequence conservation just beyond the homeobox termed the Rx domain (Fig. 2a) . Multiple Rx homologues are known in the zebrafish, medaka, chicken, and frog, and these can be divided into two paralogous groups (Casarosa et al., 1997; Chuang et al., 1999; Deschet et al., 1999; Ohuchi et al., 1999) . Homeodomain genes of this type are well known to regulate morphogenesis. Second, Rx is one of the earliest retinal patterning genes to be expressed, preceding Pax6 and Chx10. It first appears at day E7.5 in regions of the anterior neural plate and headfold that are fated to become retina and is expressed most intensely in the optic vesicle and cup between days E9 and E11 (Fig. 1c) . Rx is relatively specific to the developing eye but also appears in the ventral forebrain, presumptive hypothalamus, and posterior pituitary (Furukawa et al., 1997; Mathers et al., 1997) . This expression pattern has been generally well conserved during vertebrate evolution. A Drosophila homologue is expressed in the developing brain and clypeolabrum but does not have a major role in eye morphogenesis (Eggert et al., 1998) . Third, Rx is required for optic vesicle formation. Mice homozygous for an Rx null allele are anophthalmic but also die at birth with major central nervous system and craniofacial defects (Mathers et al., 1997) .
To evaluate Rx as a candidate for ey1, we determined its genomic structure and DNA sequence in ZRDCT, CAST/Ei, and two conventional laboratory strains (Fig.  2b) . The mouse Rx gene spans 5.6 kb and is divided into three exons. We discovered a single nucleotide change in the coding region that is unique to ZRDCT mice. The change (ATG3 TTG) causes an M10L amino acid substitution and destroys an NcoI restriction site (Fig. 2b, c) . To confirm the relationship between Rx(M10L) and ey1, we surveyed a variety of laboratory strains, wild-caught mice, and other Mus species by PCR and NcoI digestion (Fig. 2d) . The M10L mutation was found in ZRDCT mice from different sources but was absent from all other mice tested, including C57BL strains which have a 4-10% (Dietrich et al., 1994 ). An additional 21 eyeless F2 mice were typed at Rx/rax and D18Mit184. No recombination was observed between these two markers and ey1. f, ZRDCT; Ⅺ, CAST/Ei genotypes. (c) Whole-mount in situ hybridization showing Rx/rax mRNA in the optic vesicle of E9.5 and optic cup of E10.5 embryos. Expression in the optic cup is confined to the presumptive neural retina and does not extend into the choroid fissure.
background frequency of anophthalmia (Chase, 1942; Pierro and Spiggle, 1967; Robinson et al., 1993; Smith et al., 1994) and may share a common ancestry (Beck et al., 2000; Chase, 1944) with the extinct B strain that is the progenitor of ZRDCT. Moreover, a methionine codon is present at position 10 in Rx genes of all other mammals examined, including humans, rats, and six additional phylogenetically diverse rodent species, and at the equivalent position in Rx genes of fish, amphibians, and birds (Fig. 3a , left, and data not shown). This methionine codon thus exhibits a level of evolutionary sequence conservation exceeding that found among vertebrate Rx homeodomains, which are Ն96% identical. It is thus improbable that the L10 allele is segregating within mouse populations as a neutral polymorphism. We conclude that Rx(M10L) is most likely the ey1 determinant.
In principle, the M10L mutation could affect intrinsic properties of the Rx protein or the efficiency of translation initiation. Although this methionine codon appears to have been selectively retained among vertebrates for at least 400 million years, the mutation itself is a conservative amino acid substitution (an exchange between hydrophobic residues) and does not occur within a previously defined functional domain. The identity of the Rx start codon is also unclear, since the sequence surrounding the first in-frame methionine codon (M1) conforms poorly to the consensus for translation initiation compared with M10. In particular, the M1 site lacks a G at position ϩ4 and a purine at position Ϫ3, which are considered critical for ribosome recognition via a capdependent scanning mechanism (Kozak, 1996) . These three sequence characteristics are common to all vertebrate Rx genes (Fig. 3a, right) . The choice of initiation site can also be significantly influenced by mRNA secondary structure (Kozak, 1990) . To determine the true initiation site and the effect of the M10L mutation in vivo, we compared the size of Rx-myc fusion proteins translated in cells transfected with mutant or wild-type plasmid constructs (Fig. 3b) . The fusion mRNAs contain 5Ј UTR sequences and the first 66 potential codons of the mouse Rx gene. Proteins initiating at codons 1 or 10 are predicted to be 18.8 or 17.9 kDa, respectively. We also tested control constructs containing an M1L substitution or an optimal initiation sequence at M1. When the wild-type fusion construct was tested, both methionine codons were utilized as translation start sites (lane 6), consistent with a leaky scanning model (Kozak, 1995) . The relative abundance of these two proteins presumably reflects the balance between competing factors that favor initiation at M1 (proximity to the 5Ј m7G cap) versus M10 (context superiority for engaging the 40S ribosomal subunit). The M10L mutation prevented initiation at codon 10 and significantly lowered the efficiency of Rx translation overall (compare lanes 5 and 6). The decrease in translation efficiency was demonstrated
FIG. 3. The Rx(M10L) mutation affects translation initiation. (a)
Left: N-terminal alignment of vertebrate Rx proteins. Sequences were obtained from GenBank and are numbered in relation to mouse Rx/rax. Methionines (red) and residues that differ from mouse Rx/rax (blue) are indicated. The methionine at position 9, 10, or 11 has been conserved during evolution. Right: Comparison of M1 and M9 -11 translational start sites in vertebrate Rx mRNAs. The optimal sequence for translation initiation (Kozak, 1996) is shown below each alignment, and the nucleotide matches are indicated in red text. In each case, the downstream site is a significantly more favorable context than M1. (b) Western analysis of Rx-myc fusion polypeptides translated in vivo (transfected 293T cells). Left: Western blot showing Myc-tagged proteins initiating at M1, M10, or M73 (within the pCS2MT vector). Lanes 1 and 2 contain mixtures of cell extracts from lanes 3ϩ5 and lanes 4ϩ5, respectively. The ␣-tubulin blot below is a loading control. Right: Magnified view of Myc Western blot (lanes 4 -6). The diagram below shows the framework pCS2MT expression construct and predicted protein products. Wild-type Rx mRNA starts translation at both M1 and M10 codons. The M1૽ mRNA starts translation exclusively at M1, whereas the M1L mRNA starts translation exclusively at M10. The M10L mutation eliminates the shorter product and decreases overall translation efficiency. MT, myc tag; ૽, optimal start site. most clearly by the appearance of an 11.1 kDa immunoreactive protein; this reflects ribosome scanning past both codons 1 and 10 and initiation at the first in-frame AUG codon of the pCS2MT vector (compare lanes 5 and 7). In contrast, the reciprocal M1L mutation prevented initiation at codon 1 in vivo but did not significantly lower overall translation (lane 4).
To assess the effect of the M10L mutation quantitatively in the context of the full-length Rx transcript, we compared Rx protein levels in fetal retinal cells that were transfected with either a mutant or wild-type expression plasmid (Fig. 4a) . These plasmids express the entire Rx mRNA, including the open reading frame and UTRs, but differ by a single nucleotide. We observed a significant reduction in the abundance of Rx protein (compare lanes 3-6), which can best be explained by a decrease in translation efficiency. The mutation does not destabilize Rx mRNA, since wild-type and M10L transcripts were equally abundant in this experiment (data not shown) and in heterozygous (C3H/HeJ ϫ ZRDCT) F1 embryos (Fig. 4b) .
Finally, as a further functional test, we compared the activity of Rx isoforms in a Xenopus RNA microinjection assay (Andreazzoli et al., 1999; Mathers et al., 1997) . We first tested an M9L substitution in frog Xrx1 cDNA that is equivalent to the ZRDCT mouse Rx mutation. When injected into a D.1 blastomere of an 8-cell frog embryo, M9L and wild-type Xrx1 RNAs were both capable of inducing ectopic pigmented epithelium, although neither caused significant expansion of neural retina (data not shown). We then compared the activity of mouse Rx proteins initiating at M1 or M10 and M1-initiated proteins with methionine or leucine at codon 10. We observed a wide range of abnormal phenotypes on the injected sides, including small or absent eyes, cyclopia, retinal disruption, and ectopic pigmented epithelium along the optic stalk (data not shown). These results confirm that eye morphogenesis is sensitive to Rx dos- 1-4) . The wild-type product is cleaved by NcoI (554 bp) but the mutant product is resistant (824 bp). These alleles are equally represented in the heterozygotes, suggesting that the mRNAs are similarly expressed and stable. No product was amplified in the absence of reverse transcriptase.
age. (Fig. 5) (Table 1 ). However, there was no significant qualitative difference between the mutant and wild-type isoforms or between proteins initiating at M1 or M10 in their effect on frog eye development. The ey1 mutation thus does not grossly alter the intrinsic biological properties of Rx proteins.
DISCUSSION
Taken together, our findings show that ribosomes frequently bypass the suboptimal M1 site and initiate at the downstream M10 codon, producing two Rx proteins that differ by nine amino acids from one mRNA. Although rare, translational control by alternative start codon usage from a single transcript can provide a further opportunity to regulate protein function (Cornelis et al., 2000; Hann et al., 1988; Liu et al., 1997; Markussen et al., 1995; Sedman and Mertz, 1988) . While this remains a possibility for Rx, and the M10L mutation does delete the shorter isoform, we believe the primary effect of ey1 is a quantitative reduction in the synthesis of Rx polypeptide. This effect was likely to be significantly greater than two-fold a priori, since mice heterozygous for a targeted Rx null allele are phenotypically normal (Mathers et al., 1997) . Indeed, our data suggest that the M10L mutation decreases Rx translation by at least fourfold (Figs. 3b, 4a ). This result, together with (1) the meiotic linkage between Rx and ey1; (2) the unique M10L sequence alteration in the ZRDCT strain; (3) the deep evolutionary conservation of M10; (4) the established role of Rx and homeodomain proteins generally in eye development; and (5) the specific effect of M10L on alternative initiation, strongly suggests that Rx(M10L) can be equated with ey1. A potentially similar but less profound reduction in the efficiency of translation initiation was reported for a mutation in codon 2 of the human androgen receptor gene that causes a hypomorphic phenotype (Choong et al., 1996) . In contrast, missense mutations affecting solitary start codons generally cause a complete loss of function (Cheadle et al., 1994; Tsujino et al., 1994; Waye et al., 1997) . To our knowledge, Rx(M10L) is the first example of a constitutional mutation affecting an alternative start codon.
Our findings explain a number of previous observations regarding Rx and this strain. First, the eye and hypothalamic phenotypes of ZRDCT mice closely match the Rx expression pattern. Second, the M10L substitution is compatible with the behavior of ey1 as a hypomorphic allele. This is manifest during embryogenesis by a graded reduction in the size of the optic vesicle and in the adult phenotype. Third, explant data show an intrinsic growth defect in the neural retina of ZRDCT embryos but not in lens primordia (Koniukhov and Iakovlev, 1986) . Within the mouse eye, Rx expression is limited to the optic cup and neural retina and is relatively independent of Pax6 (Bernier et al., 2000; Zhang et al., 2000; NB and TG, unpublished observations) . Accordingly, microphthalmia or anophthalmia can result from mutations in patterning genes that are expressed in the optic cup, lens, or both (Breitman et al., 1987; Burmeister et al., 1996; Ferda Percin et al., 2000; Hill et al., 1991; Hodgkinson et al., 1993) .
Approximately one-half to two-thirds of the F2 mice homozygous for the Rx(M10L) mutation have normally sized eyes. This conclusion follows from the phenotypic segregation data, which show fewer affected mice than the 25% expected for a single recessive mendelian factor; the absence of excess perinatal lethality among the F2 progeny and parental ZRDCT mice; and the finding of M10L homozygotes in the normal F2 progeny class (data not shown). The Rx(M10L) mutation is thus necessary but not sufficient to produce anophthalmia in the ZRDCT strain. This decreased penetrance and the phenotypic variability among affected F2 mice are reminiscent of anophthalmia and microphthalmia in some human pedigrees (Bateman, 1984) . Our results suggest that RX mutations may underlie some of these human disorders (Voronina and Mathers, 2000) . The inheritance pattern also suggests that unlinked modifier gene(s), are likely to interact with Rx in a developmental pathway for the eye or otherwise control the threshold for phenotypic expression of ey1. Although a single modifier (ey2) was originally proposed by Chase (1944) , the actual number of modifiers cannot be determined from segregation data alone (Beck, 1963; Wright, 1968) , since their individual dominance characteristics and potential epistatic relationships are unknown. This number, however, is likely to be small. The discovery of ey1 provides a basis to identify these genes. Comparable modifier loci have been defined for mutations affecting limb morphogenesis (Johnson et al., 1995; Sidow et al., 1997) and other eye diseases (Bone-Larson et al., 2000; Chang et al., 1999; Kajiwara et al., 1994) .
Finally, as a synthetic trait involving a partial loss-offunction mutation, the ZRDCT phenotype is suggestive of the quantitative, polygenic interactions that underlie the appearance and loss of morphological characteristics during evolution (Grenier and Carroll, 2000; Wright, 1968) . Extreme eye reduction is typical of troglobitic (cave-dwelling) and fossorial species, which are found within every class of vertebrates except birds. Adaptive loss of function (Olson, 1999) involving quantitative changes in the activity of genes such as Rx may thus contribute to ocular regression in naturally blind species (Cooper et al., 1993; Wilkens, 1971; Yamamoto and Jeffery, 2000) .
METHODS

Mice
The inbred ZRDCT strain (aa bb dd pp) was derived (Beck, 1963) from the original B strain (bb dd) of Herman Chase, who received founders directly from C.C. Little in 1938 (Chase, 1942) . The eyeless phenotype was first noted at the Jackson Laboratory within a colony of strain R mice, among progeny of a wide cross, and was positively selected by Little during the initial breeding (Chase, 1949; Snell, 1941) . To generate intersubspecific F2 mice, we crossed eyeless ZRDCT males and females to inbred Mus musculus castaneus mice (CAST/Ei, obtained from the Jackson Laboratory) and intercrossed the resulting F1 progeny. Phenotypes were scored two weeks after birth when the eyelids had opened. Eyes were classified according to Chase (1942) as normal, small, or absent, and individual F2 pups as normal, eyeless (bilateral anophthalmia), or intermediate (microphthalmia or unilateral anophthalmia). In cases where the lids remained closed, the conjunctival sacs were explored and generally found to be anophthalmic. For RNA analysis, we crossed ZRDCT males to C3H/HeJ females and recovered F1 embryos on day E14.5 of gestation.
PCR Genotyping
A genome scan was performed using 58 SSLP markers distributed across the autosomes (Dietrich et al., 1994) . Genomic DNA from 12 severely affected F2 mice was divided into two equal pools (Taylor et al., 1994) . Markers were amplified for 40 cycles using standard PCR conditions and primer pairs (Research Genetics). Short, secondary PCRs (10 cycles) were then performed with one 32 P-end-labeled primer and the products separated by electrophoresis through 6% polyacrylamide sequencing gels. F2 pools were compared with ZRDCT, CAST/Ei, and F1 genomic DNA controls. Once linkage was detected, by an enrichment of ZRDCT alleles in the pooled DNA, a larger set of 54 eyeless F2 mice was typed individually using additional markers on chromosome 18.
Rx Gene Analysis
Overlapping segments of mouse Rx were amplified from ZRDCT, C3H/HeJ, C57BL/6J, and CAST/Ei genomic DNA by high-fidelity long-range PCR (EXPAND, Roche) using primers designed from the cDNA sequence (Furukawa et al., 1997; Mathers et al., 1997) . Betaine (20% v/v MasterAmp, Epicentre) was included in some reactions to improve yield of GC-rich products. Terminal fragments were recovered from BamHI-digested genomic DNA by inverse PCR (Ochman et al., 1990) . The amplified products were sequenced directly and used to assemble two Rx contigs. These are separated by 2.1 kb and correspond to exons 1-2 and 3 (accession nos. AF319462 and AF319461). To localize Rx directly in the F2 cross, we typed a 3-bp insertion in the second intron, using PCR primers 5Ј-CCTGTGGGTCAGAGAG-GATAGCGAC-3Ј and 5Ј-CTGGCGCCTCCACTTAGCCCG-TCGG-3Ј which span 265 bp. Southern analysis of mouse genomic DNA was performed using a 785-bp 5Ј Rx cDNA probe (Mathers et al., 1997) and high stringency wash conditions (0.1 ϫ SSC, 65°C). To demonstrate the M10L Rx mutation, a 361-bp fragment of exon 1 was amplified using primers 5Ј-CTAAACTTGCAGCTCCAG-CAGCGGG-3Ј and 5Ј-GCCCAGGATGGCTTCGATGCT-GTG-3Ј and digested with NcoI. The wild-type PCR product is cleaved into 269-and 92-bp fragments, but the M10L product is resistant to cleavage. We used this assay to survey normal inbred laboratory mice (A/J, AU/SsJ, a Other phenotypes we observed include: no eyes, with random pigmentation along the midline of the anterior head (most common); one eye displaced anteriorly at midline; and no eyes, with no pigmentation.
BALB/cJ, CBA/J, C3H/HeJ, C57BL/6J, C57BL/10J, C57BR/ cdJ, C57L/J, C58/J, DBA/2J, LT/ChRe, SJL/J, SWR/J, 129/ SvJ); Mus musculus castaneus (CAST/Ei), Mus spretus (SPE/Ei), Mus musculus molossinus (MOLF/Ei), and a Peruvian strain (PERA), each obtained as DNA from the Jackson Laboratory; wild-caught Mus musculus and Mus domesticus from the hybrid zone of Northern Europe (kindly provided by Richard Sage); and eyeless ZRDCT mice from colonies in Rhode Island (Harch et al., 1978) and Moscow (Konyukhov et al., 1978) , which have been maintained separately for more than 20 years (kindly provided by Neil Gonsalves and Boris Konyukhov).
RNA Analysis
Whole-mount in situ hybridization was performed on wild-type CD1 mouse embryos as described (Brown et al., 1998 ) using a 5Ј Rx cDNA probe (Mathers et al., 1997) . To test whether the M10L mutation affects transcript stability, we performed a reverse transcriptase (RT) PCR assay on (C3H/HeJ ϫ ZRDCT) F1 embryos. Total RNA from E14.5 heads was randomly primed and used to amplify 824-bp Rx cDNA products spanning exons 1-3 with PCR primers 5Ј-CTAAACTTGCAGCTC-CAGCAGCGGG-3Ј and 5Ј-CTGGCGCCTCCACTTAGC-CCGTCGG-3Ј. The reverse primer was 32 P-end-labeled and the PCR was for 30 cycles. Mutant and wild-type transcripts differ by a single nucleotide. Their relative abundance was determined by cleaving the radiolabeled PCR products with NcoI and comparing the ratio of 824-and 554-bp allelic fragments after polyacrylamide gel electrophoresis. The two alleles amplified equally in control reactions performed on F1 genomic DNA.
Rx Plasmids
Mouse Rx cDNA clones with M10L and M1L mutations (ATG3 TTG) or optimal translation initiation sites (Kozak, 1996) M1૽ and M10૽ (GCCACCATGG) were created by oligonucleotide mutagenesis and restriction endonuclease selection (Deng and Nickoloff, 1992 ). An M9L mutation was introduced by the same method into a frog Xrx1 cDNA clone in the pSP64RI vector (kindly provided by Pete Mathers). Full-length mouse Rx expression constructs were created in pCS2 by ligating XbaIBsrGI fragments from 5Ј and 3Ј cDNA clones (Mathers et al., 1997) . To determine the exact site of translation initiation, a panel of mutant and wild-type Rx-myc fusion constructs was created in pCS2MT (Rupp et al., 1994; Turner and Weintraub, 1994) . The expression cassettes contain 86 bp of 5ЈUTR and the 66 amino-terminal codons of mouse Rx, followed in frame by six tandem Myc epitopes, and are transcribed in vivo from the simian CMV promoter. Fusion polypeptides starting at codons M1 or M10 contain 166 or 157 amino acids, respectively. The fusion constructs also contain an optimal translation initiation sequence (AAAGCTATGG) at M73 within the pCS2MT vector.
Cell Culture and Protein Analysis
Translation initiation was studied in vivo using 293T human embryonic kidney cells. Cultures were transfected with pCS2(Rx-myc) or control pCS2MT plasmids by CaPO 4 co-precipitation (2.5 g per 60-mm dish). After 48 h, whole-cell extracts were harvested in cold lysis buffer (50 mM Tris, 150 mM NaCl, 1% NP40, pH 8.0) and clarified by centrifugation. To resolve fusion proteins in the size range between 17 and 19 kDa, supernatants were electrophoresed through a 14-cm 18% polyacrylamide gel for 10 h at 14 V/cm. The gel buffer was 350 mM Bis-Tris, pH 6.5 and the running buffer was 50 mM MOPS, 50 mM Tris, 0.1% SDS, 1 mM EDTA, pH 7.7. Myc-tagged proteins were detected in Western blots using 9E10 monoclonal antibody (1:200), HRP-conjugated sheep anti-mouse IgG (1:20,000, Amersham), and enhanced chemiluminescence (ECL) reagents (Renaissance, NEN). To confirm the interpretation of migration patterns, selected cell extracts from mutant and control transfections were mixed and coelectrophoresed. Similar results were obtained for pCS2(Rx-myc) constructs in three different transfection experiments. To verify that an equivalent amount of cell extract was loaded in each lane and control for transfection efficiency, we probed nitrocellulose filters with a monoclonal antibody (DM1A) that detects endogenous ␣-tubulin (1:200, Neomarkers) or co-transfected a plasmid encoding an unrelated Myc-tagged protein.
To assess the efficiency of Rx translation overall, duplicate 60-mm cultures of Ad12 HER10 human embryonic retinal cells (Grabham et al., 1988) were co-transfected in parallel with 1.0 g of the full-length mutant or wild-type Rx expression constructs or pCS2 vector. Plasmid DNAs were introduced using FuGENE6 reagent (Roche). After 60 h, soluble proteins were extracted from cells by lysis in cold RIPA buffer (150 mM NaCl, 1.0% NP40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) and electrophoresed through 10% polyacrylamide SDS Bis-Tris gels (Novex, 20 g per lane). After transfer, Western blots were probed in series with polyclonal rabbit anti-RX IgG (1:200) and DM1A (␣-tubulin). The anti-RX IgG was purified from whole rabbit serum (Kimura et al., 2000) . Primary antibodies were detected using HRP-protein A (1:5,000, KPL) or HRP-conjugated sheep anti-mouse IgG (1:20,000, Amersham) and ECL reagents (NEN). The relative abundance of Rx protein was determined by densitometry from multiple ECL exposures. The Rx mRNA levels in transfected cells were equivalent by RT-PCR.
Xenopus RNA Microinjection
Capped RNA from wild-type and M9L mutant Xrx1 cDNA clones was synthesized in vitro using SP6 polymerase (Ambion) and microinjected using standard techniques (Kanekar et al., 1997) into one of two D.1 blastomeres in 8-cell Xenopus embryos. These dorsal blastomeres normally form retinae, brain, and other anterior structures (Bauer et al., 1994) . The injected Xrx1 transcripts contain rabbit ␤-globin UTR sequences but are not polyadenylated. We tested a range of Xrx1 RNA amounts from 50 to 200 pg and co-injected a ␤-gal tracer RNA (50 pg). Similar experiments were performed using 10 to 68 pg capped mouse Rx RNA derived from wildtype, M1L, M10L, M1૽, M10૽ and M1૽/M10L clones in pCS2 (Rupp et al., 1994; Turner and Weintraub, 1994) ; these transcripts contain an SV40 polyA cassette that can be utilized by injected Xenopus embryos, leading to significantly higher levels of protein expression (D.L. Turner, personal communication). Embryos were stained for ␤-galactosidase at stage 39 -41 and evaluated under the dissection microscope and by histology. Toxicity was assessed by comparing the extent of staining in embryos co-injected with Rx and ␤-gal RNAs to embryos injected with ␤-gal RNA alone. Abnormal phenotypes were assessed in comparison with the contralateral uninjected sides as described (Mathers et al., 1997) .
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